Review: taking Warfarin sodium and Zetia together


Summary

Drug interactions are reported among people who take Warfarin sodium and Zetia together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Zetia. It is created by eHealthMe based on reports of 2,489 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 53,624 users)

Zetia

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. (latest outcomes from Zetia 32,499 users)

On Sep, 15, 2016

2,489 people who take Warfarin Sodium, Zetia are studied.


Number of reports submitted per year:

Warfarin sodium and Zetia drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 75.0% - (3 of 4 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 100.0% - (1 of 1 people)
Zetia:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 3 people)
  • 2 - 5 years: 71.0% - (5 of 7 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 50.0% - (4 of 8 people)
  • male: 70.0% - (7 of 10 people)
Zetia:
  • female: 50.0% - (4 of 8 people)
  • male: 36.0% - (4 of 11 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 66.0% - (10 of 15 people)
Zetia:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 43.0% - (7 of 16 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • dehydration
  • haemoglobin decreased
  • renal failure acute
  • alanine aminotransferase increased
  • anaemia
  • aspartate aminotransferase increased
  • atrial fibrillation
  • haematocrit decreased
  • nausea
1 - 6 months:
  • international normalised ratio increased
  • cerebrovascular accident
  • atrial fibrillation
  • myocardial infarction
  • pain
  • platelet count decreased
  • alopecia
  • cardiac failure congestive
  • gait disturbance
  • alanine aminotransferase increased
6 - 12 months:
  • fall
  • nausea
  • subdural haematoma
  • abdominal discomfort
  • abdominal pain upper
  • arthritis
  • back pain
  • bone pain
  • diarrhoea
  • eye irritation
1 - 2 years:
  • alopecia
  • haemorrhage
  • atrial fibrillation
  • cellulitis
  • cerebellar haemorrhage
  • contusion
  • deep vein thrombosis
  • gastrointestinal haemorrhage
  • gingivitis
  • haemoglobin decreased
2 - 5 years:
  • malaise
  • muscular weakness
  • myalgia
  • asthenia
  • back disorder
  • gastric atony
  • hernia
  • pain
  • international normalised ratio increased
  • abdominal pain
5 - 10 years:
  • deep vein thrombosis
  • haemorrhage
  • myositis
  • pulmonary embolism
  • contusion
  • international normalised ratio increased
  • low income
  • myopathy
  • pain in extremity
  • haemorrhagic stroke
10+ years:
  • cardiac failure
  • grand mal convulsion
  • international normalised ratio increased
  • migraine
  • pain
  • renal impairment
  • respiratory failure
  • unresponsive to stimuli
  • withdrawal syndrome
  • hypoxic-ischaemic encephalopathy
not specified:
  • dyspnoea
  • fatigue
  • atrial fibrillation
  • asthenia
  • dizziness
  • pain
  • anxiety
  • international normalised ratio increased
  • fall
  • nausea

Most common drug interactions by gender *:

female:
  • pain
  • asthenia
  • fatigue
  • dyspnoea
  • anxiety
  • fall
  • atrial fibrillation
  • injury
  • depression
  • dizziness
male:
  • dyspnoea
  • atrial fibrillation
  • dizziness
  • fatigue
  • cardiac failure congestive
  • international normalised ratio increased
  • hypotension
  • oedema peripheral
  • anaemia
  • asthenia

Most common drug interactions by age *:

0-1:
  • atrioventricular block complete
  • hypertension
  • pain in extremity
  • syncope
20-29:
  • pneumonia
  • appendicitis
  • back pain
  • blood immunoglobulin g decreased
  • cystitis
  • dehydration
  • diarrhoea
  • dyslipidaemia
  • gastroenteritis
  • hyperlipidaemia
30-39:
  • convulsion
  • asthenia
  • type 2 diabetes mellitus
  • anxiety
  • cardiovascular disorder
  • dysphagia
  • fatigue
  • injury
  • pain
  • pain in jaw
40-49:
  • hypotension
  • pain
  • nephrogenic systemic fibrosis
  • cerebrovascular accident
  • pain in extremity
  • dyspnoea
  • hypoxia
  • injection site erythema
  • injection site pain
  • nausea
50-59:
  • hypotension
  • depression
  • pain
  • pyrexia
  • pneumonia
  • arthralgia
  • renal failure acute
  • pulmonary hypertension
  • cardiac failure congestive
  • deep vein thrombosis
60+:
  • dyspnoea
  • atrial fibrillation
  • dizziness
  • fatigue
  • international normalised ratio increased
  • asthenia
  • pain
  • fall
  • nausea
  • anxiety

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Zetia?

Can you answer these questions?

More questions for: Warfarin sodium, Zetia

You may be interested in these reviews

More reviews for: Warfarin sodium, Zetia

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Zetia (ezetimibe) is often used to treat high blood cholesterol. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.